Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × gallium 68 PSMA-11 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 66 Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Hepatocellular 3 Prostatic Diseases 2 Ovarian Neoplasms 2 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Renal Insufficiency 1 Prostatic Neoplasms, Castration-Resistant 1 Prostate-specific Membrane Antigen 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer (mCRPC) 1 Melanoma 1 Lung Neoplasms 1 Genital Neoplasms, Male 1 Genital Diseases, Male 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Lobular 1 Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 254 Nivolumab 232 Ipilimumab 210 aldesleukin 119 Cyclophosphamide 117 Interleukin-2 88 trametinib 74 dabrafenib 66 Dacarbazine 62 Vemurafenib 60 fludarabine 59 Temozolomide 59 fludarabine phosphate 52 Biopsy 43 Radiosurgery 41 sargramostim 39 Bevacizumab 39 incomplete Freund's adjuvant 35 binimetinib 34 Paclitaxel 32 Magnetic Resonance Spectroscopy 32 atezolizumab 31 Specimen Handling 31 Radiotherapy 31 Cisplatin 31 Introns 30 cobimetinib 29 Blood Specimen Collection 29 encorafenib 28 Carboplatin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06560905 2025-07-01

PPPIMS

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡